-
Published14/09/2013
-
Deadline29/10/2013
-
Today13/02/2026
Utilities
- indicates text translated automatically in your browsing language
France-Bagnolet: Pharmacy services
Inserm in collaboration with the European Vaccine Initiative (EVI) aims to develop a vaccine against gestational malaria. In this context, INSERM U665 has identified a region of var2CSA for which it wishes to subcontract the development of the production process in E. Coli and purification comprising:
(1) the development of purification on a scale of 50-100 litres.
(2) development of analytical methods
(3) carrying out accelerated stability studies
(4) the transfer of production to a biopharmaceutical processor for the production of a clinical batch requiring a final report and the sending of personnel to the site.
This consultation takes the form of an open invitation to tender pursuant to Articles 28 and 29 of the Decree.
no 2005-1742 of 30 December 2005, as amended and adopted pursuant to the Order of 6 June 2005.
Framework agreement with single operator
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.